By defining a functional signaling pathway, i.e., SNHG1/DNMT3A/miR-129-2-5p/Rac1, that drives stemness and invasion in advanced bladder cancer cells, our study should spur additional investigation into the value of therapeutically targeting components of this pathway. This evidence concerns the gene SNHG1 and urinary bladder cancer.